Cytogen's IPO

Cytogen raised a round of funding on February 13, 2006. Investors include Public.

Cytogen is developing, and commercializing a portfolio of oncology products. Caphosol is an approved electrolyte solution for the treatment of oral mucositis and dry mouth that is seen during chemothe…

Articles about Cytogen's IPO: